CA2530460C - Procede de traitement du syndrome coronarien aigu - Google Patents

Procede de traitement du syndrome coronarien aigu Download PDF

Info

Publication number
CA2530460C
CA2530460C CA2530460A CA2530460A CA2530460C CA 2530460 C CA2530460 C CA 2530460C CA 2530460 A CA2530460 A CA 2530460A CA 2530460 A CA2530460 A CA 2530460A CA 2530460 C CA2530460 C CA 2530460C
Authority
CA
Canada
Prior art keywords
therapeutic agent
formulation
group
encapsulated
embedded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2530460A
Other languages
English (en)
Other versions
CA2530460A1 (fr
Inventor
Elazer R. Edelman
Gershon Golomb
Haim D. Danenberg
Yoram Richter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zuli Holdings Ltd
Original Assignee
Biorest Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/607,623 external-priority patent/US10517883B2/en
Application filed by Biorest Ltd filed Critical Biorest Ltd
Publication of CA2530460A1 publication Critical patent/CA2530460A1/fr
Application granted granted Critical
Publication of CA2530460C publication Critical patent/CA2530460C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2530460A 2003-06-27 2004-06-24 Procede de traitement du syndrome coronarien aigu Expired - Fee Related CA2530460C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10/607,623 US10517883B2 (en) 2003-06-27 2003-06-27 Method of treating acute myocardial infarction
US10/607,623 2003-06-27
US10/871,488 2004-06-18
US10/871,488 US9498488B2 (en) 2003-06-27 2004-06-18 Method of treating acute coronary syndromes
PCT/US2004/020487 WO2005002545A1 (fr) 2003-06-27 2004-06-24 Procede de traitement du syndrome coronarien aigu

Publications (2)

Publication Number Publication Date
CA2530460A1 CA2530460A1 (fr) 2005-01-13
CA2530460C true CA2530460C (fr) 2012-08-14

Family

ID=33568009

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2530460A Expired - Fee Related CA2530460C (fr) 2003-06-27 2004-06-24 Procede de traitement du syndrome coronarien aigu

Country Status (4)

Country Link
JP (1) JP4621202B2 (fr)
AU (1) AU2004253527B2 (fr)
CA (1) CA2530460C (fr)
WO (1) WO2005002545A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
US20060051407A1 (en) * 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
AU2006215300C9 (en) * 2005-02-17 2010-05-06 Hadasit Medical Research Services And Development Ltd. Bisphosphonates for treating endometriosis
US9943481B2 (en) * 2005-05-26 2018-04-17 Biorest Ltd. Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
US9867838B2 (en) * 2009-09-01 2018-01-16 Duke University Methods for treating heart failure using bisphosphonate compositions
US9949992B2 (en) 2011-11-16 2018-04-24 Duke University Bisphosphonate compositions and methods for treating and\or reducing cardiac dysfunction
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
EP3142670B1 (fr) * 2014-05-16 2018-08-22 Biorest Ltd. Utilisation de bisphosphonates en tant que traitement d'appoint contre le vih/sida

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
AU7525296A (en) * 1995-11-01 1997-05-22 Chiron Corporation Treatment of a cardiovascular indication by delivery of therapeutics to the pericardial space
DE19637890A1 (de) * 1996-09-17 1998-03-19 Max Planck Gesellschaft Biphosphonat-Liposomen
IL125336A0 (en) * 1998-07-14 1999-03-12 Yissum Res Dev Co Compositions for inhibition and treatment of restinosis
PL367102A1 (en) * 2001-05-02 2005-02-21 Purdue Research Foundation Treatment and diagnosis of macrophage mediated disease

Also Published As

Publication number Publication date
JP2007524632A (ja) 2007-08-30
AU2004253527B2 (en) 2010-04-08
AU2004253527A1 (en) 2005-01-13
WO2005002545A8 (fr) 2006-02-16
WO2005002545A1 (fr) 2005-01-13
JP4621202B2 (ja) 2011-01-26
CA2530460A1 (fr) 2005-01-13

Similar Documents

Publication Publication Date Title
US10213446B2 (en) Method of treating acute coronary syndromes
CA2596679C (fr) Procede de traitement de lesion d'ischemie-reperfusion
US6984400B2 (en) Method of treating restenosis using bisphosphonate nanoparticles
US20070166385A1 (en) Method of inhibiting restenosis using bisphosphonates
CA2530460C (fr) Procede de traitement du syndrome coronarien aigu
US20050153937A1 (en) Desensitization of compliment activation using monocyte/macrophage inhibitory compounds

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20200831